The 10 new flu-related deaths in children bring the season's total to 226, the most since 2009-10.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Though US COVID-19 cases have dropped sharply, progress is uneven, with some regions vulnerable to further surges.
The latest epidemiological analyis showed a 11-day doubling time, and lab studies yielded new details on vaccine protection against Delta.
Some African countries that have vaccine are having challenges deploying it, even some that are experiencing surges.
Black COVID-19 patients were more likely to die or be discharged to hospice after 30 days of hospitalization compared with White patients, according to a study today in JAMA Network Open. The researchers add, though, that the largest factor was the overall mortality and hospice rates of the hospitals where patients were treated.
Multidrug-resistant organisms (MDROs) were isolated in more than a quarter of South Korean patients with confirmed COVID-19 pneumonia and microbial culture results, with corticosteroid use identified as a significant risk factor, researchers reported yesterday in the American Journal of Infection Control.
In other developments, the CDC adds Delta as a variant of concern and issues its first guidance on "long COVID."
The findings are from the UK Recovery trial, which was large enough to gauge a true effect on death in hospitalized patients.
GAO's latest report looks at the VA's three main supply chain, COVID-related adaptations.
Also, the WHO adds a variant of interest first detected in Peru last August, which it labeled Lambda.
An analysis of data from 211 Connecticut nursing homes found that facilities that cared for mainly racial and ethnic minority residents had higher levels of COVID-19 illnesses and deaths. A team based at the University of Rochester in New York reported their findings today in Infection Control & Hospital Epidemiology.
